To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCNB1IP1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
486 supporting clones for gene CCNB1IP1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_182849.1   .a 1 to 1288 1 to 1288 exact RefSeq, AAA   1288/1288
(100 %)
0 diff
(100 %id)
BM857384 stomach .a 19 to 400 1 to 382   tiling clone,   382/382
(100 %)
0 diff
(100 %id)
BM856712 stomach .a 19 to 338 1 to 320       320/320
(100 %)
0 diff
(100 %id)
BM741937 Ascites, stomach .a 20 to 633 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BM741203 Ascites, stomach .a 20 to 600 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BM741413 Ascites, stomach .a 20 to 652 1 to 633       633/633
(100 %)
0 diff
(100 %id)
BM757056 Ascites, stomach .a 20 to 433 1 to 414       414/414
(100 %)
0 diff
(100 %id)
BM756973 Ascites, stomach .a 20 to 588 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BM784807 Ascites, stomach .a 20 to 437 1 to 418       418/418
(100 %)
0 diff
(100 %id)
BM771026 Ascites, stomach .a 20 to 482 1 to 463       463/463
(100 %)
0 diff
(100 %id)
BG036785 adenocarcinoma, cell line, Prostate .a 26 to 741 13 to 725       713/972
(73 %)
23 diff
(97.7 %id)
BM561746 blood, natural killer cells, cell line .a 38 to 991 1 to 961       961/961
(100 %)
18 diff
(98.2 %id)
BX407501 neuroblastoma .a 45 to 1124 1 to 1067 F239X S242L T244Q A245H P246X ...     1067/1067
(100 %)
16 diff
(98.6 %id)
BX425626 neuroblastoma .a 45 to 998 1 to 954       954/954
(100 %)
10 diff
(99.0 %id)
CN308704 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 45 to 384 29 to 368       341/368
(92 %)
6 diff
(98.4 %id)
CN308709 embryonic stem cells, cell lines H1, H7, andH9 .a 45 to 774 8 to 737       731/737
(99 %)
7 diff
(99.1 %id)
CR601801 neuroblastoma .a 45 to 1291 1 to 1247 exact tiling clone,   1247/1247
(100 %)
0 diff
(100 %id)
BF027892 bladder, carcinoma, cell line .a 45 to 574 15 to 537       525/897
(58 %)
16 diff
(98.3 %id)
BG396891 eye, retinoblastoma .a 45 to 735 23 to 714       693/986
(70 %)
30 diff
(97.0 %id)
BF971451 adrenal cortex carcinoma, cell line, adrenal gland .a 47 to 741 1 to 697       697/697
(100 %)
5 diff
(99.3 %id)
BF317380 brain, neuroblastoma .a 58 to 794 1 to 735       735/735
(100 %)
8 diff
(99.0 %id)
BI197843 brain, neuroblastoma .a 58 to 830 1 to 789       789/1143
(69 %)
30 diff
(97.4 %id)
CN308691 embryonic stem cells, DMSO-treated H9 cellline .a 59 to 700 1 to 642       642/642
(100 %)
1 diff
(99.9 %id)
BM014376 breast, mammary adenocarcinoma, cell line .a 60 to 868 1 to 809       809/809
(100 %)
8 diff
(99.1 %id)
TI_59392382   .a 60 to 868 51 to 859       809/809
(100 %)
8 diff
(99.1 %id)
DN993177 brain, whole brain .a 62 to 727 9 to 674       666/674
(98 %)
8 diff
(98.9 %id)
BX425281 neuroblastoma .a 84 to 1207 1 to 1116 Y171F P209H L210*     1116/1138
(98 %)
26 diff
(97.8 %id)
CN308697 embryonic stem cells, cell lines H1, H7, andH9 .a 84 to 419 1 to 336       336/336
(100 %)
1 diff
(99.8 %id)
CR624788 neuroblastoma .a 84 to 1289 1 to 1206 exact     1206/1206
(100 %)
0 diff
(100 %id)
BF886679 testis_normal .a 91 to 412 335 to 14     Submitted on the opposite strand 322/350
(92 %)
1 diff
(99.8 %id)
BM741929 Ascites, stomach .a 99 to 638 1 to 540       540/540
(100 %)
0 diff
(100 %id)
R57700   .a 106 to 278 1 to 172       172/172
(100 %)
7 diff
(96.0 %id)
BM741248 stomach .a 111 to 639 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
BM745835 stomach .a 111 to 536 1 to 426       426/426
(100 %)
1 diff
(99.8 %id)
BM753647 stomach .a 111 to 660 1 to 549       549/549
(100 %)
4 diff
(99.3 %id)
BM764450 stomach .a 111 to 735 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
CN308703 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 112 to 513 1 to 402       402/402
(100 %)
2 diff
(99.6 %id)
BI199395 brain, neuroblastoma .a 118 to 707 1 to 613       574/659
(87 %)
35 diff
(94.7 %id)
BM753158 stomach .a 118 to 477 2 to 368       373/368
(101 %)
11 diff
(97.1 %id)
BE934293 head_neck .a 122 to 470 10 to 356       348/356
(97 %)
8 diff
(97.8 %id)
BG500664 adenocarcinoma, Prostate .a 127 to 576 186 to 643       458/730
(62 %)
20 diff
(97.3 %id)
CN308702 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 139 to 666 1 to 528       528/528
(100 %)
4 diff
(99.3 %id)
BQ940510 brain, neuroblastoma, cell line .a 144 to 979 1 to 842       842/853
(98 %)
12 diff
(98.6 %id)
AA328248   .a 151 to 493 1 to 343       343/343
(100 %)
2 diff
(99.5 %id)
AW962383   .a 152 to 754 1 to 608       608/614
(99 %)
18 diff
(97.1 %id)
BQ723311 sympathetic trunk .a 160 to 707 1 to 556       556/1121
(49 %)
24 diff
(97.9 %id)
BM796949 Ascites, stomach .a 202 to 640 1 to 439       439/439
(100 %)
1 diff
(99.8 %id)
CN308696 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 231 to 958 9 to 734       730/734
(99 %)
6 diff
(99.2 %id)
BG216721   .a 240 to 1033 1 to 791       791/794
(99 %)
35 diff
(95.6 %id)
BG753702 eye, normal pigmented retinal epithelium .a 240 to 1184 1 to 951 C10V N11I Y12I R13E K14S ...     951/986
(96 %)
40 diff
(96.0 %id)
BX407500 neuroblastoma .a 243 to 1260 1019 to 1 L3X C4X D6B M7X K14X ...     1019/1028
(99 %)
13 diff
(98.8 %id)
TI_154054998   .a 250 to 1288 1107 to 87 S2C L3V C4K E5T D6S ... AAA   1021/1022
(99 %)
28 diff
(97.3 %id)
BX407654 brain, fetal brain .a 253 to 1277 1025 to 1 S2L L3C C4V E5K D6T ...     1025/1030
(99 %)
22 diff
(97.9 %id)
BF698239 brain, primitive neuroectoderm .a 256 to 897 1 to 644       644/902
(71 %)
18 diff
(98.1 %id)
BX457941 neuroblastoma .a 261 to 1244 989 to 9 S2F L3V C4*     981/995
(98 %)
26 diff
(97.4 %id)
TI_1948091042   .a 268 to 900 126 to 761       636/1161
(54 %)
10 diff
(99.2 %id)
BM466119 embryonal carcinoma, cell line, testis .a 269 to 1039 1 to 774       774/1093
(70 %)
26 diff
(97.7 %id)
CB128698 Liver .a 270 to 891 1 to 622       622/622
(100 %)
0 diff
(100 %id)
AF216381   .a 276 to 1109 1 to 834 exact     834/834
(100 %)
0 diff
(100 %id)
CV025445 mixed .a 276 to 807 1 to 532       532/532
(100 %)
1 diff
(99.9 %id)
BG475975 melanotic melanoma, skin .a 277 to 1103 1 to 847       847/847
(100 %)
67 diff
(92.1 %id)
BM826482 Ascites, stomach .a 290 to 903 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BE390040 endometrium, adenocarcinoma cell line, uterus .a 297 to 900 1 to 605       605/607
(99 %)
2 diff
(99.7 %id)
BE385071 melanotic melanoma, skin .a 297 to 910 1 to 614       614/615
(99 %)
3 diff
(99.6 %id)
CB129976 Liver .a 303 to 894 1 to 592       592/592
(100 %)
0 diff
(100 %id)
R09257 liver and spleen .a 304 to 651 1 to 362       362/403
(89 %)
22 diff
(94.6 %id)
TI_154054958   .a 309 to 1288 1057 to 95   AAA   963/999
(96 %)
28 diff
(97.2 %id)
BE786578 large cell carcinoma, lung .a 316 to 1011 1 to 691       691/908
(76 %)
14 diff
(98.5 %id)
AA341281 Kidney .a 320 to 672 1 to 354       354/354
(100 %)
2 diff
(99.5 %id)
CR621988 HeLa cells Cot 25-normalized .a 323 to 1286 1 to 964       964/964
(100 %)
0 diff
(100 %id)
BX346766   .a 323 to 1255 945 to 11       935/945
(98 %)
29 diff
(97.0 %id)
BX346767   .a 323 to 1247 1 to 925       925/925
(100 %)
0 diff
(100 %id)
BM018714 astrocytoma grade IV, cell line, brain .a 327 to 1120 1 to 797       797/802
(99 %)
7 diff
(99.2 %id)
TI_59389382   .a 328 to 1120 99 to 894       796/801
(99 %)
6 diff
(99.3 %id)
CD356918 Blood vessels - aorta, basilar and artery .a 330 to 907 1 to 581       581/806
(72 %)
9 diff
(98.9 %id)
CN308695 embryonic stem cells, cell lines H1, H7, andH9 .a 333 to 860 13 to 539       527/539
(97 %)
6 diff
(98.9 %id)
BU177069 melanotic melanoma, skin .a 338 to 910 1 to 578       578/1034
(55 %)
19 diff
(98.2 %id)
BF819040 colon_ins .a 345 to 890 10 to 555       546/555
(98 %)
7 diff
(98.8 %id)
BX404151 neuroblastoma .a 346 to 1289 943 to 1       943/943
(100 %)
23 diff
(97.6 %id)
CN308723 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 354 to 871 1 to 518       518/518
(100 %)
0 diff
(100 %id)
BX400753   .a 364 to 1253 891 to 1       891/891
(100 %)
22 diff
(97.6 %id)
BX374061   .a 427 to 1286 857 to 1       857/857
(100 %)
9 diff
(99.0 %id)
BQ345408 nervous_tumor .a 473 to 943 487 to 14       474/496
(95 %)
9 diff
(98.2 %id)
CD238661 Pituitary .a 478 to 1213 1 to 736       736/736
(100 %)
4 diff
(99.5 %id)
BX346885 Placenta Cot 25-normalized .a 495 to 1278 1 to 782       782/786
(99 %)
4 diff
(99.5 %id)
BQ678229 melanotic melanoma, cell line, skin .a 498 to 1034 237 to 774       538/959
(56 %)
12 diff
(98.8 %id)
BM852377 Ascites, stomach .a 506 to 1100 1 to 595       595/595
(100 %)
1 diff
(99.9 %id)
CA418497 Chondrosarcoma Grade II, Left Pelvis .a 511 to 1288 794 to 19   AAA   776/776
(100 %)
2 diff
(99.8 %id)
TI_57228842   .a 515 to 1166 93 to 743       651/654
(99 %)
6 diff
(99.1 %id)
BI869221 adenocarcinoma, cell line, Liver .a 516 to 1166 1 to 650       650/653
(99 %)
6 diff
(99.1 %id)
BQ223690 embryonal carcinoma, cell line, testis .a 532 to 1288 1 to 757   AAA   757/757
(100 %)
0 diff
(100 %id)
BM855154 Ascites, stomach .a 532 to 980 1 to 450       450/450
(100 %)
2 diff
(99.6 %id)
BX340896   .a 571 to 1233 675 to 11       550/675
(81 %)
9 diff
(98.7 %id)
AW367190 head_neck .a 621 to 874 1 to 255       255/255
(100 %)
6 diff
(97.7 %id)
EH340636   .a 710 to 783 1 to 75       75/76
(98 %)
2 diff
(97.4 %id)
R09155 liver and spleen .a 1011 to 1276 278 to 11       268/283
(94 %)
0 diff
(100 %id)
AW377158 colon .b 1 to 743 1 to 742   tiling clone,   742/742
(100 %)
13 diff
(98.3 %id)
BE178070 head_neck .b 52 to 282 10 to 236   tiling clone,   227/236
(96 %)
7 diff
(97.1 %id)
N78526 multiple sclerosis lesions .b 230 to 473 1 to 244   tiling clone,   244/244
(100 %)
0 diff
(100 %id)
N38855 multiple sclerosis lesions .b 277 to 478 1 to 202       202/204
(99 %)
3 diff
(98.6 %id)
N38856 multiple sclerosis lesions .b 600 to 1109 516 to 1   tiling clone,   516/516
(100 %)
7 diff
(98.7 %id)
N73683 multiple sclerosis lesions .b 634 to 1109 483 to 1   tiling clone,   483/487
(99 %)
6 diff
(98.8 %id)
DB107746 thymus .c 1 to 575 6 to 580   tiling clone, capped   579/579
(100 %)
1 diff
(99.9 %id)
CF139305 CNCAP(3)T-225 cell line, Prostate .c 53 to 496 1 to 444       444/444
(100 %)
8 diff
(98.2 %id)
TI_154169517   .c 60 to 547 89 to 577       489/994
(49 %)
8 diff
(99.2 %id)
CN308693 embryonic stem cells, DMSO-treated H9 cellline .c 130 to 798 1 to 669 exact tiling clone,   669/669
(100 %)
0 diff
(100 %id)
BX500918 Liver .d-u 1 to 671 1 to 671   tiling clone,   671/671
(100 %)
6 diff
(99.2 %id)
BE148269 head_neck .d-u 479 to 913 1 to 434 Q50K tiling clone,   434/434
(100 %)
12 diff
(97.3 %id)
BM477840 leiomyosarcoma, uterus .e 1 to 728 1 to 729   tiling clone,   729/1088
(67 %)
20 diff
(98.2 %id)
F12422 brain, total brain .e 356 to 662 1 to 307       307/307
(100 %)
4 diff
(98.7 %id)
BX161423 placenta .e 360 to 1963 1 to 1604 exact tiling clone,   1604/1604
(100 %)
0 diff
(100 %id)
NM_182851.1   .e 360 to 2021 1 to 1662 exact RefSeq, AAA   1662/1662
(100 %)
0 diff
(100 %id)
AL543081 placenta, Placenta Cot 25-normalized .e 364 to 1295 1 to 951       840/957
(87 %)
41 diff
(95.8 %id)
BX368025 Placenta Cot 25-normalized .e 743 to 1453 712 to 5       708/712
(99 %)
7 diff
(99.1 %id)
BQ017550 lung, Lung Focal Fibrosis .e 754 to 1327 12 to 585     Submitted on the opposite strand 574/574
(100 %)
7 diff
(98.8 %id)
BQ936071 large cell carcinoma, lung .e 935 to 1767 29 to 863       835/982
(85 %)
14 diff
(98.6 %id)
F10039 brain, total brain .e 1753 to 2018 266 to 1   tiling clone,   266/266
(100 %)
0 diff
(100 %id)
DA539119 Kidney .f 1 to 568 9 to 576   tiling clone, capped   575/575
(100 %)
5 diff
(99.2 %id)
DA010629 adrenal gland .f 3 to 560 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BX461277 brain, fetal brain .f 262 to 1165 14 to 918       905/1076
(84 %)
12 diff
(98.9 %id)
BX247978 fetal brain .f 270 to 1862 1 to 1593 exact tiling clone,   1593/1593
(100 %)
0 diff
(100 %id)
BX461276 brain, fetal brain .f 1185 to 1860 677 to 1       677/1037
(65 %)
18 diff
(98.3 %id)
BF681152 Prostate .g 1 to 567 7 to 582       582/582
(100 %)
26 diff
(95.6 %id)
DB029392 testis .g 1 to 455 2 to 457   tiling clone, capped   456/593
(76 %)
3 diff
(99.5 %id)
BP432648   .g 5 to 333 1 to 329       329/329
(100 %)
2 diff
(99.4 %id)
BI917081 brain .g 9 to 787 1 to 779       779/783
(99 %)
2 diff
(99.8 %id)
TI_57182820   .g 9 to 851 93 to 932       840/932
(90 %)
16 diff
(98.3 %id)
TI_57242368   .g 9 to 787 34 to 812       779/816
(95 %)
8 diff
(99.1 %id)
BI771433 pooled lung and spleen .g 14 to 851 1 to 835       835/835
(100 %)
12 diff
(98.6 %id)
NM_021178.3   .g 14 to 1501 1 to 1488 exact RefSeq, AAA   1488/1488
(100 %)
0 diff
(100 %id)
BP245085 Kidney .g 18 to 598 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
CB113193 Liver .g 18 to 574 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
BG613960 embryonal carcinoma, testis .g 22 to 753 1 to 733       733/734
(99 %)
10 diff
(98.7 %id)
DA315519 hippocampus .g 23 to 561 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
AL161994 brain .g 24 to 1500 5 to 1481 exact tiling clone, available from DKFZ, AAA   1477/1477
(100 %)
4 diff
(99.8 %id)
AA282623.
matches multiple genes
germinal center B cell .g 24 to 454 1 to 431     also hits gene RAD51L3andRFFL 431/431
(100 %)
1 diff
(99.8 %id)
DA357907 subthalamic nucleus .g 26 to 593 2 to 570   capped   569/569
(100 %)
6 diff
(99.0 %id)
BG528144 lung, mucoepidermoid carcinoma .g 27 to 732 1 to 713       713/854
(83 %)
22 diff
(97.5 %id)
BM763080 myeloma .g 27 to 656 1 to 630       630/630
(100 %)
2 diff
(99.7 %id)
AK225253 dermoid cancer .g 28 to 1491 1 to 1464 exact     1464/1464
(100 %)
1 diff
(100.0 %id)
AK226037 dermoid cancer .g 28 to 1501 1 to 1474 exact AAA   1474/1474
(100 %)
1 diff
(100.0 %id)
BP226111   .g 28 to 609 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BF980792 duodenal adenocarcinoma, cell line, small intestine .g 28 to 754 1 to 720       722/931
(77 %)
15 diff
(98.4 %id)
CB123588 Liver .g 28 to 694 1 to 667       667/667
(100 %)
4 diff
(99.5 %id)
DA833518 placenta .g 28 to 699 2 to 675   capped   674/676
(99 %)
12 diff
(98.3 %id)
DB192252 ovary, tumor tissue .g 28 to 588 2 to 563   capped   562/562
(100 %)
6 diff
(99.0 %id)
BP246581 Kidney .g 29 to 611 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA681639 ovary .g 29 to 602 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA740350   .g 29 to 546 2 to 519   capped   518/518
(100 %)
0 diff
(100 %id)
DA075178 cerebellum .g 31 to 570 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DB272622 uterus .g 31 to 587 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA386266 thalamus .g 32 to 607 2 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
BJ991122 hepatoblastoma .g 32 to 614 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BG572126 placenta .g 32 to 636 1 to 608       608/608
(100 %)
7 diff
(98.9 %id)
DA616916   .g 32 to 616 2 to 587   capped   586/586
(100 %)
4 diff
(99.4 %id)
DA681665 ovary .g 32 to 567 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
AK026233 human small intestine .g 33 to 1501 1 to 1469 exact available from FLJ, AAA   1469/1469
(100 %)
2 diff
(99.9 %id)
AK225451 small intestine .g 33 to 1501 1 to 1469 exact AAA   1469/1469
(100 %)
2 diff
(99.9 %id)
BP261124 small intestine .g 33 to 614 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP261513 small intestine .g 33 to 599 1 to 568       568/568
(100 %)
2 diff
(99.7 %id)
DB190883 lung, tumor tissue .g 33 to 612 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
BP376360 uterus .g 33 to 586 1 to 554       554/554
(100 %)
2 diff
(99.7 %id)
DA132046 alzheimer cortex .g 34 to 591 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BG494499 lung, mucoepidermoid carcinoma .g 34 to 787 1 to 759       759/768
(98 %)
24 diff
(96.9 %id)
BG494600 lung, mucoepidermoid carcinoma .g 34 to 607 1 to 572       572/572
(100 %)
5 diff
(99.2 %id)
DA608209   .g 34 to 590 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA616801   .g 34 to 608 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA731655   .g 34 to 561 2 to 534   capped   533/546
(97 %)
6 diff
(99.0 %id)
BP380901   .g 34 to 443 1 to 411       411/416
(98 %)
2 diff
(99.6 %id)
CN308706 embryonic stem cells, DMSO-treated H9 cellline .g 36 to 727 1 to 692       692/692
(100 %)
6 diff
(99.2 %id)
BF211111 bone marrow, from chronic myelogenous leukemia .g 37 to 628 1 to 593       593/594
(99 %)
12 diff
(98.0 %id)
BQ774054 Bone, Human Chondrosarcoma Cell Line .g 37 to 763 19 to 747     Submitted on the opposite strand 729/729
(100 %)
3 diff
(99.6 %id)
BF239980 bone marrow, from chronic myelogenous leukemia .g 38 to 530 1 to 488       488/784
(62 %)
14 diff
(98.3 %id)
CB115545 Liver .g 39 to 686 1 to 646       646/646
(100 %)
6 diff
(99.1 %id)
CX785465 human embryonic stem cells .g 42 to 824 1 to 783       783/783
(100 %)
0 diff
(100 %id)
T32687 heart .g 43 to 332 1 to 290       290/290
(100 %)
0 diff
(100 %id)
BI197115 brain, neuroblastoma .g 44 to 934 1 to 900       900/1145
(78 %)
33 diff
(97.2 %id)
BG472058 eye, retinoblastoma .g 45 to 827 1 to 783       783/787
(99 %)
6 diff
(99.3 %id)
D56488   .g 46 to 281 1 to 239       239/240
(99 %)
8 diff
(96.7 %id)
BF794485 lymph, lymphoma, cell line .g 46 to 700 1 to 656       656/955
(68 %)
8 diff
(99.2 %id)
BQ882818 eye, normal pigmented retinal epithelium .g 46 to 960 1 to 921       921/923
(99 %)
22 diff
(97.7 %id)
BU501695 brain, neuroblastoma, cell line .g 46 to 892 1 to 866       866/935
(92 %)
35 diff
(96.3 %id)
CN308707 embryonic stem cells, DMSO-treated H9 cellline .g 50 to 583 1 to 534       534/534
(100 %)
1 diff
(99.9 %id)
BF797923 lymph, lymphoma, cell line .g 50 to 785 1 to 735       735/971
(75 %)
12 diff
(98.8 %id)
BG395814 eye, retinoblastoma .g 50 to 787 2 to 733       732/832
(87 %)
11 diff
(98.7 %id)
BG471919 eye, retinoblastoma .g 50 to 859 2 to 818       817/862
(94 %)
22 diff
(97.5 %id)
BG471764 eye, retinoblastoma .g 50 to 775 1 to 726       726/726
(100 %)
0 diff
(100 %id)
BI334158 cervical carcinoma cell line, cervix .g 50 to 862 1 to 814       814/814
(100 %)
3 diff
(99.7 %id)
BQ053161 blood, natural killer cells, cell line .g 50 to 1017 24 to 1003       980/1102
(88 %)
20 diff
(98.2 %id)
BQ223050 large cell carcinoma, lung .g 52 to 892 1 to 848       848/897
(94 %)
16 diff
(98.3 %id)
BU193442 eye, retinoblastoma .g 52 to 913 1 to 869       869/870
(99 %)
25 diff
(97.2 %id)
CN308692 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 53 to 646 1 to 594       595/594
(100 %)
7 diff
(98.9 %id)
CN308701 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 53 to 709 1 to 656       656/656
(100 %)
5 diff
(99.3 %id)
CN308719 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 53 to 664 1 to 612       612/612
(100 %)
1 diff
(99.9 %id)
BE799515 lung, small cell carcinoma .g 53 to 838 27 to 813       789/813
(97 %)
12 diff
(98.6 %id)
BF313236 brain, neuroblastoma .g 53 to 825 1 to 760       759/909
(83 %)
26 diff
(97.2 %id)
BF529004 anaplastic oligodendroglioma with 1p/19qloss, brain .g 53 to 678 1 to 627       627/907
(69 %)
12 diff
(98.7 %id)
BG107663 Bone, osteosarcoma, cell line .g 53 to 700 1 to 646       646/901
(71 %)
12 diff
(98.7 %id)
BG164314 hypernephroma, cell line, Kidney .g 53 to 731 1 to 679       678/960
(70 %)
14 diff
(98.6 %id)
Z44956 brain, total brain .g 54 to 433 1 to 380       380/380
(100 %)
0 diff
(100 %id)
CN308686 embryonic stem cells, DMSO-treated H9 cellline .g 54 to 523 1 to 470       470/470
(100 %)
1 diff
(99.8 %id)
CN308725 embryonic stem cells, DMSO-treated H9 cellline .g 54 to 743 1 to 690       690/695
(99 %)
1 diff
(99.9 %id)
BF569701 Kidney, renal carcinoma (ascites) .g 54 to 668 1 to 615   fully sequenced,   615/615
(100 %)
4 diff
(99.4 %id)
BG336059 choriocarcinoma, placenta .g 54 to 787 1 to 724       724/872
(83 %)
29 diff
(96.7 %id)
BG329350 eye, retinoblastoma .g 54 to 396 1 to 348       348/1085
(32 %)
10 diff
(99.1 %id)
BG765524 melanotic melanoma, high MDR (cell line), skin .g 54 to 211 1 to 158       158/191
(82 %)
5 diff
(97.4 %id)
BM927154 brain .g 54 to 1029 1 to 987       987/1046
(94 %)
41 diff
(96.1 %id)
BC001218 Muscle, rhabdomyosarcoma .g 55 to 1501 1 to 1447 exact tiling clone, available from MGC, AAA   1447/1447
(100 %)
0 diff
(100 %id)
CN308698 embryonic stem cells, DMSO-treated H9 cellline .g 55 to 556 1 to 503       503/503
(100 %)
3 diff
(99.5 %id)
CR591184 fetal brain .g 55 to 1489 1 to 1435 exact     1435/1435
(100 %)
0 diff
(100 %id)
CR612618 B cells (Ramos cell line) Cot 25-normalized .g 55 to 1464 1 to 1410 exact     1410/1410
(100 %)
0 diff
(100 %id)
BX459769 brain, fetal brain .g 55 to 778 1 to 725   fully sequenced,   725/725
(100 %)
5 diff
(99.4 %id)
BX363626   .g 55 to 787 1 to 733       733/937
(78 %)
3 diff
(99.7 %id)
BF203226 muscle, rhabdomyosarcoma .g 55 to 776 1 to 724       724/1049
(69 %)
11 diff
(99.0 %id)
BF204961 muscle, rhabdomyosarcoma .g 55 to 786 1 to 731       731/928
(78 %)
25 diff
(97.4 %id)
BG107538 Bone, osteosarcoma, cell line .g 55 to 622 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
BG258099 embryonal carcinoma, cell line, testis .g 55 to 607 1 to 553       553/553
(100 %)
1 diff
(99.9 %id)
BI113951 muscle, rhabdomyosarcoma .g 55 to 757 1 to 702       702/702
(100 %)
5 diff
(99.3 %id)
BI907012 leukocyte .g 55 to 725 1 to 672       672/672
(100 %)
3 diff
(99.6 %id)
BM470292 eye, retinoblastoma .g 55 to 720 91 to 762   AAA   675/1341
(50 %)
16 diff
(98.9 %id)
ES308936 occipital hair of pubic hypotrichosispatient, skin .g 56 to 640 1 to 587       587/587
(100 %)
9 diff
(98.5 %id)
BG026684 Bone, osteosarcoma, cell line .g 56 to 825 1 to 766       768/937
(81 %)
16 diff
(98.3 %id)
BQ049940 lymph, lymphoma, cell line .g 56 to 958 1 to 909       909/1056
(86 %)
9 diff
(99.2 %id)
BQ217094 large cell carcinoma, lung .g 56 to 879 1 to 836       836/841
(99 %)
12 diff
(98.6 %id)
BQ954278 leiomyosarcoma, uterus .g 56 to 904 1 to 850       850/851
(99 %)
7 diff
(99.2 %id)
DR155698 human embryonic stem cells differentiated toan early endodermal cell type .g 56 to 848 1 to 793       793/793
(100 %)
1 diff
(99.9 %id)
T34408 lung .g 56 to 263 1 to 208       208/211
(98 %)
4 diff
(98.2 %id)
BE019358 muscle, rhabdomyosarcoma .g 57 to 624 1 to 568       568/568
(100 %)
5 diff
(99.2 %id)
BF683599 leiomyosarcoma cell line, uterus .g 57 to 556 1 to 500       500/500
(100 %)
1 diff
(99.8 %id)
BU171076 eye, retinoblastoma .g 57 to 920 1 to 873       873/892
(97 %)
14 diff
(98.5 %id)
BU178878 eye, retinoblastoma .g 57 to 944 1 to 896       896/903
(99 %)
13 diff
(98.6 %id)
BG898398 cartilage .g 58 to 398 89 to 429       343/362
(94 %)
8 diff
(97.8 %id)
BG900070 cartilage .g 58 to 391 91 to 424       336/354
(94 %)
8 diff
(97.8 %id)
CN308688 embryonic stem cells, DMSO-treated H9 cellline .g 58 to 717 14 to 673       661/673
(98 %)
7 diff
(99.0 %id)
CN308699 embryonic stem cells, DMSO-treated H9 cellline .g 58 to 717 22 to 682       662/682
(97 %)
8 diff
(98.9 %id)
CN308711 embryonic stem cells, DMSO-treated H9 cellline .g 58 to 726 13 to 681       670/681
(98 %)
7 diff
(99.0 %id)
CN308718 embryonic stem cells, cell lines H1, H7, andH9 .g 58 to 664 12 to 618       608/618
(98 %)
6 diff
(99.1 %id)
CN308720 embryonic stem cells, DMSO-treated H9 cellline .g 58 to 679 12 to 634       625/634
(98 %)
10 diff
(98.5 %id)
AW247482.
matches multiple genes
lung, small cell carcinoma .g 58 to 400 10 to 352     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base), also hits gene SNTB2andVPS4A 343/352
(97 %)
7 diff
(98.1 %id)
BE798661 lung, small cell carcinoma .g 58 to 914 25 to 880       857/931
(92 %)
30 diff
(96.8 %id)
BG394008 embryonal carcinoma, cell line, testis .g 58 to 787 71 to 802       734/1217
(60 %)
19 diff
(98.5 %id)
BI089591 cervix .g 58 to 859 17 to 825       808/825
(97 %)
27 diff
(96.8 %id)
BM451325 eye, retinoblastoma .g 58 to 955 17 to 918       903/1033
(87 %)
29 diff
(97.2 %id)
BM471515 eye, retinoblastoma .g 58 to 553 17 to 514       499/1262
(39 %)
19 diff
(98.5 %id)
BU158609 embryonal carcinoma, cell line, testis .g 58 to 925 25 to 898       876/898
(97 %)
18 diff
(98.0 %id)
BQ422789 melanotic melanoma, skin .g 58 to 731 21 to 710       692/942
(73 %)
41 diff
(95.7 %id)
BU192727 eye, retinoblastoma .g 58 to 882 28 to 854       828/854
(96 %)
17 diff
(98.1 %id)
BU602444 mixed (pool of 40 RNAs) .g 58 to 720 17 to 682       666/736
(90 %)
12 diff
(98.4 %id)
CA949938 Pancreas, Purified pancreatic islet .g 58 to 679 11 to 632       624/632
(98 %)
7 diff
(98.9 %id)
TI_57233563   .g 58 to 725 35 to 703       672/703
(95 %)
6 diff
(99.2 %id)
BP429931   .g 58 to 441 10 to 395       387/395
(97 %)
6 diff
(98.5 %id)
DN991070 brain, whole brain .g 58 to 660 33 to 634       602/636
(94 %)
9 diff
(98.6 %id)
BC000369 Lung, small cell carcinoma .g 59 to 1495 1 to 1438 exact available from MGC, AAA   1438/1438
(100 %)
1 diff
(100.0 %id)
BC004435 Lung, small cell carcinoma .g 59 to 1495 1 to 1438   available from MGC, AAA   1438/1438
(100 %)
1 diff
(100.0 %id)
CR593880 neuroblastoma .g 59 to 1445 1 to 1388 exact     1388/1388
(100 %)
1 diff
(100.0 %id)
CR596432 Placenta Cot 25-normalized .g 59 to 1156 1 to 1099       1099/1099
(100 %)
1 diff
(100.0 %id)
CR603010 neuroblastoma .g 59 to 1483 1 to 1426 exact     1426/1426
(100 %)
1 diff
(100.0 %id)
CR611584 neuroblastoma .g 59 to 1477 1 to 1420 exact     1420/1420
(100 %)
1 diff
(100.0 %id)
BX457563 neuroblastoma .g 59 to 787 1 to 730       730/1044
(69 %)
4 diff
(99.7 %id)
BX438166 neuroblastoma .g 59 to 825 1 to 767   fully sequenced,   767/767
(100 %)
6 diff
(99.3 %id)
BX457942 neuroblastoma .g 59 to 792 1 to 735       735/793
(92 %)
27 diff
(96.6 %id)
BX458138 neuroblastoma .g 59 to 778 1 to 721       721/1054
(68 %)
5 diff
(99.6 %id)
BX407655 brain, fetal brain .g 59 to 1023 1 to 963       963/963
(100 %)
8 diff
(99.2 %id)
BX440531 brain, fetal brain .g 59 to 1051 1 to 993       993/993
(100 %)
2 diff
(99.8 %id)
BX402248 Placenta Cot 25-normalized .g 59 to 734 1 to 677   fully sequenced,   677/677
(100 %)
2 diff
(99.8 %id)
BX356632 Placenta Cot 25-normalized .g 59 to 976 1 to 919       919/919
(100 %)
5 diff
(99.5 %id)
BX371006 Placenta Cot 25-normalized .g 59 to 940 1 to 881       881/881
(100 %)
6 diff
(99.4 %id)
AA446219   .g 59 to 641 1 to 583       583/583
(100 %)
9 diff
(98.5 %id)
BE514989 adenocarcinoma cell line, ovary .g 59 to 674 1 to 625       625/626
(99 %)
23 diff
(96.4 %id)
BG028409 Bone, osteosarcoma, cell line .g 59 to 669 1 to 615       615/615
(100 %)
7 diff
(98.9 %id)
BG829065 muscle, rhabdomyosarcoma .g 59 to 447 1 to 392       392/1120
(35 %)
11 diff
(99.1 %id)
BI857373 breast, mammary adenocarcinoma, cell line .g 59 to 861 1 to 801       801/803
(99 %)
6 diff
(99.3 %id)
BM559285 eye, retinoblastoma .g 59 to 1085 1 to 1030       1030/1033
(99 %)
22 diff
(97.9 %id)
BU169904 large cell carcinoma, lung .g 59 to 893 1 to 847       847/919
(92 %)
36 diff
(96.1 %id)
BU182182 eye, retinoblastoma .g 59 to 936 1 to 888       888/890
(99 %)
16 diff
(98.3 %id)
BQ642590 lymph, lymphoma, cell line .g 59 to 937 1 to 886       886/927
(95 %)
21 diff
(97.8 %id)
TI_57187505   .g 59 to 861 53 to 854       802/804
(99 %)
7 diff
(99.2 %id)
T32759 heart .g 59 to 316 1 to 258       258/260
(99 %)
3 diff
(98.9 %id)
BM011816 brain, neuroblastoma, cell line .g 60 to 787 1 to 729       729/801
(91 %)
12 diff
(98.6 %id)
BM455326 lymph, lymphoma, cell line .g 60 to 956 1 to 899       899/1121
(80 %)
24 diff
(97.9 %id)
BQ221066 large cell carcinoma, lung .g 60 to 759 1 to 704       704/953
(73 %)
23 diff
(97.6 %id)
TI_59380993   .g 61 to 787 101 to 828       728/800
(91 %)
11 diff
(98.7 %id)
CN308715 embryonic stem cells, DMSO-treated H9 cellline .g 62 to 524 1 to 463       463/463
(100 %)
1 diff
(99.8 %id)
AA223863 brain, neuroepithelial cells .g 62 to 436 1 to 376       376/376
(100 %)
3 diff
(99.3 %id)
AA171573   .g 63 to 493 1 to 434       434/435
(99 %)
8 diff
(98.2 %id)
BG519771 brain, neuroblastoma .g 63 to 940 1 to 877       877/881
(99 %)
13 diff
(98.6 %id)
BE793438 lung, small cell carcinoma .g 63 to 816 1 to 752       752/752
(100 %)
10 diff
(98.7 %id)
CN308712 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 64 to 717 1 to 657       657/657
(100 %)
5 diff
(99.3 %id)
BE314596 brain, neuroblastoma .g 64 to 783 40 to 761       722/997
(72 %)
14 diff
(98.6 %id)
BE786897 large cell carcinoma, lung .g 64 to 697 1 to 634       634/1163
(54 %)
8 diff
(99.4 %id)
R57579   .g 65 to 408 1 to 341       341/342
(99 %)
5 diff
(98.6 %id)
CN308717 embryonic stem cells, DMSO-treated H9 cellline .g 66 to 526 1 to 461       461/461
(100 %)
1 diff
(99.8 %id)
AA205108   .g 66 to 178 1 to 114       114/114
(100 %)
2 diff
(98.3 %id)
BE794648 lung, small cell carcinoma .g 66 to 868 1 to 798       798/854
(93 %)
18 diff
(97.9 %id)
CN308687 embryonic stem cells, DMSO-treated H9 cellline .g 67 to 498 1 to 432       432/432
(100 %)
2 diff
(99.6 %id)
CN308694 embryonic stem cells, DMSO-treated H9 cellline .g 67 to 728 1 to 663       663/663
(100 %)
2 diff
(99.7 %id)
CN308708 embryonic stem cells, DMSO-treated H9 cellline .g 69 to 531 1 to 464       464/464
(100 %)
2 diff
(99.6 %id)
CN308722 embryonic stem cells, DMSO-treated H9 cellline .g 69 to 450 1 to 382       382/382
(100 %)
0 diff
(100 %id)
BE254619 eye, retinoblastoma .g 69 to 663 1 to 594       594/595
(99 %)
3 diff
(99.5 %id)
BU855288 ovary, teratocarcinoma, cell line .g 69 to 768 1 to 706       706/862
(81 %)
17 diff
(98.1 %id)
BF036999 adenocarcinoma, ovary .g 70 to 787 1 to 717       717/766
(93 %)
10 diff
(98.7 %id)
T32787 heart .g 70 to 359 1 to 291       291/291
(100 %)
1 diff
(99.7 %id)
BM263179 Islets of Langerhans, Pancreas .g 71 to 601 1 to 531       531/531
(100 %)
0 diff
(100 %id)
CN308721 embryonic stem cells, DMSO-treated H9 cellline .g 72 to 671 1 to 600       600/600
(100 %)
0 diff
(100 %id)
BE251438 eye, retinoblastoma .g 73 to 703 1 to 628       628/700
(89 %)
7 diff
(99.0 %id)
BE264451 lung, small cell carcinoma .g 73 to 709 1 to 637       637/637
(100 %)
1 diff
(99.9 %id)
BE746964 adenocarcinoma cell line, ovary .g 73 to 861 1 to 794       794/831
(95 %)
24 diff
(97.2 %id)
BE790731 lung, small cell carcinoma .g 73 to 787 1 to 722       722/969
(74 %)
10 diff
(99.0 %id)
BE796536 lung, small cell carcinoma .g 73 to 890 1 to 816       816/927
(88 %)
22 diff
(97.7 %id)
CN308714 embryonic stem cells, DMSO-treated H9 cellline .g 74 to 828 1 to 755       755/755
(100 %)
0 diff
(100 %id)
BE279214 choriocarcinoma, placenta .g 74 to 593 1 to 522       522/523
(99 %)
4 diff
(99.3 %id)
BE262373 brain, neuroblastoma .g 74 to 664 1 to 591       591/591
(100 %)
1 diff
(99.9 %id)
BE313627 brain, neuroblastoma .g 74 to 787 1 to 715       715/810
(88 %)
24 diff
(97.1 %id)
BE294125 muscle, rhabdomyosarcoma .g 74 to 579 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
BE295059 muscle, rhabdomyosarcoma .g 74 to 787 1 to 715       715/748
(95 %)
11 diff
(98.6 %id)
BE295823 muscle, rhabdomyosarcoma .g 74 to 521 1 to 449       449/449
(100 %)
2 diff
(99.6 %id)
BE794622 lung, small cell carcinoma .g 74 to 855 1 to 773       773/959
(80 %)
16 diff
(98.4 %id)
BE250267 muscle, rhabdomyosarcoma .g 75 to 778 1 to 703       703/862
(81 %)
2 diff
(99.8 %id)
AW402943 lymph .g 75 to 524 1 to 449       449/449
(100 %)
5 diff
(98.9 %id)
BE875209 large cell carcinoma, undifferentiated, lung .g 75 to 783 1 to 706       706/744
(94 %)
8 diff
(99.0 %id)
BE539799 cervix .g 76 to 788 1 to 709       709/722
(98 %)
18 diff
(97.6 %id)
BE790359 large cell carcinoma, lung .g 76 to 738 1 to 657       657/943
(69 %)
31 diff
(96.8 %id)
BF219802 lung, small cell carcinoma .g 77 to 720 1 to 643       643/644
(99 %)
6 diff
(99.1 %id)
CN308689 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 78 to 671 1 to 594       594/594
(100 %)
0 diff
(100 %id)
BE299758 muscle, rhabdomyosarcoma .g 78 to 816 1 to 736   fully sequenced,   736/736
(100 %)
1 diff
(99.9 %id)
BM694147 eye, RPE and Choroid .g 78 to 584 15 to 520       506/520
(97 %)
6 diff
(98.9 %id)
BE778687 eye, retinoblastoma .g 83 to 772 1 to 685       685/918
(74 %)
17 diff
(98.2 %id)
TI_154139489   .g 83 to 718 79 to 714       636/636
(100 %)
7 diff
(98.9 %id)
BM353711 Pancreas, Purified pancreatic islet .g 87 to 530 1 to 444       444/444
(100 %)
8 diff
(98.2 %id)
BF794145 lymph, lymphoma, cell line .g 91 to 782 1 to 696       696/839
(82 %)
13 diff
(98.5 %id)
BX450822 neuroblastoma .g 93 to 971 877 to 1       877/881
(99 %)
16 diff
(98.2 %id)
CN308690 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 96 to 733 1 to 638       638/638
(100 %)
1 diff
(99.9 %id)
BI255910 cervical carcinoma cell line, cervix .g 179 to 885 1 to 714       714/809
(88 %)
14 diff
(98.3 %id)
AA004561 liver and spleen .g 188 to 303 1 to 116       116/126
(92 %)
1 diff
(99.3 %id)
AA004571 liver and spleen .g 188 to 337 1 to 150       150/166
(90 %)
1 diff
(99.4 %id)
BM796644 Ascites, stomach .g 188 to 621 1 to 434       434/434
(100 %)
0 diff
(100 %id)
CN308724 embryonic stem cells, cell lines H1, H7, andH9 .g 199 to 587 1 to 389       389/389
(100 %)
0 diff
(100 %id)
BG112378 Bone, osteosarcoma, cell line .g 200 to 989 1 to 791       791/1008
(78 %)
44 diff
(95.7 %id)
CN308713 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 216 to 488 1 to 273       273/273
(100 %)
3 diff
(99.0 %id)
DA727487   .g 217 to 789 2 to 580   capped   579/747
(77 %)
9 diff
(98.8 %id)
CB140299 Liver .g 221 to 662 1 to 442       442/442
(100 %)
1 diff
(99.8 %id)
BE706333 head_neck .g 222 to 644 439 to 19       421/466
(90 %)
1 diff
(99.8 %id)
BF155968 head_neck .g 229 to 700 493 to 23       471/493
(95 %)
0 diff
(100 %id)
BU600861 mixed (pool of 40 RNAs) .g 240 to 1079 1 to 844       844/844
(100 %)
13 diff
(98.5 %id)
BM019533 astrocytoma grade IV, cell line, brain .g 248 to 1127 2 to 879       878/901
(97 %)
22 diff
(97.6 %id)
TI_59390220   .g 248 to 1127 93 to 970       878/900
(97 %)
22 diff
(97.6 %id)
BI194941 brain, neuroblastoma .g 249 to 893 24 to 668       645/668
(96 %)
9 diff
(98.7 %id)
AA223590 brain, neuroepithelial cells .g 273 to 598 1 to 329       329/329
(100 %)
4 diff
(98.8 %id)
T83173 liver and spleen .g 308 to 710 1 to 415       415/416
(99 %)
18 diff
(95.7 %id)
BF570441 Kidney, renal carcinoma (ascites) .g 638 to 1456 832 to 16   fully sequenced,   817/832
(98 %)
14 diff
(98.4 %id)
BX402247 Placenta Cot 25-normalized .g 704 to 1156 453 to 1   fully sequenced,   453/453
(100 %)
0 diff
(100 %id)
BX459768 brain, fetal brain .g 748 to 1489 740 to 1   fully sequenced,   740/740
(100 %)
7 diff
(99.1 %id)
BE299468 muscle, rhabdomyosarcoma .g 755 to 1421 669 to 2   fully sequenced,   668/669
(99 %)
1 diff
(99.9 %id)
BG191895   .g 783 to 1486 719 to 11     Submitted on the opposite strand 709/861
(82 %)
30 diff
(96.6 %id)
BX438543 neuroblastoma .g 783 to 1466 694 to 12       683/1031
(66 %)
3 diff
(99.8 %id)
BX363625   .g 783 to 1460 683 to 6       678/981
(69 %)
0 diff
(100 %id)
BX452899 neuroblastoma .g 785 to 1502 723 to 1       723/723
(100 %)
45 diff
(93.8 %id)
TI_154110721   .g 785 to 1501 772 to 62   AAA   711/925
(76 %)
6 diff
(99.4 %id)
CR605480 neuroblastoma .g 786 to 1502 1 to 718       718/718
(100 %)
1 diff
(99.9 %id)
BX410490 neuroblastoma .g 786 to 1502 1 to 719       719/719
(100 %)
3 diff
(99.6 %id)
BX416250 neuroblastoma .g 786 to 1502 1 to 718       718/718
(100 %)
9 diff
(98.8 %id)
CK024169 brain/CNS, Human Brain - Frontal Cortex .g 786 to 1425 1 to 640       640/640
(100 %)
1 diff
(99.9 %id)
TI_154123635   .g 786 to 1495 805 to 108   AAA   698/904
(77 %)
30 diff
(96.7 %id)
TI_154131635   .g 786 to 1501 800 to 89   AAA   712/931
(76 %)
8 diff
(99.2 %id)
TI_149312999   .g 787 to 1501 790 to 84   AAA   707/896
(78 %)
22 diff
(97.6 %id)
TI_149283917   .g 794 to 1495 784 to 83   AAA   702/702
(100 %)
0 diff
(100 %id)
BX438165 neuroblastoma .g 795 to 1483 690 to 1   fully sequenced,   690/690
(100 %)
22 diff
(96.9 %id)
BX457562 neuroblastoma .g 796 to 1445 651 to 1       651/997
(65 %)
17 diff
(98.3 %id)
AA101730 lung, lung carcinoma .g 796 to 1150 1 to 354   fully sequenced,   354/354
(100 %)
1 diff
(99.8 %id)
TI_149285864   .g 803 to 1501 785 to 87   AAA   699/699
(100 %)
0 diff
(100 %id)
BQ576273 Chondrosarcoma Grade II, Left Pelvis .g 805 to 1501 715 to 19   AAA   697/697
(100 %)
0 diff
(100 %id)
CA397378 eye, RPE/choroid .g 807 to 1190 1 to 384       384/384
(100 %)
10 diff
(97.4 %id)
AL569757 placenta, Placenta Cot 25-normalized .g 808 to 1443 640 to 1       640/963
(66 %)
10 diff
(99.0 %id)
BE781177 eye, retinoblastoma .g 808 to 1403 20 to 615       596/615
(96 %)
6 diff
(99.1 %id)
BX429170 neuroblastoma .g 813 to 1501 1 to 687       687/690
(99 %)
6 diff
(99.2 %id)
BM984301 lung .g 815 to 1495 699 to 19   AAA   681/681
(100 %)
0 diff
(100 %id)
BM971724 lung .g 824 to 1501 696 to 19   AAA   678/678
(100 %)
0 diff
(100 %id)
CN308700 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 833 to 1163 1 to 331       331/331
(100 %)
5 diff
(98.5 %id)
BI819524 pooled brain, lung, testis .g 833 to 1485 1 to 655       655/1238
(52 %)
17 diff
(98.7 %id)
BX326282 Placenta Cot 25-normalized .g 834 to 1498 8 to 674       667/674
(98 %)
7 diff
(99.0 %id)
CA418125 Bone, Human Chondrosarcoma Cell Line .g 834 to 1501 685 to 19   AAA   667/667
(100 %)
1 diff
(99.9 %id)
TI_57199380   .g 836 to 1485 35 to 686       652/1269
(51 %)
16 diff
(98.8 %id)
CA418529 Chondrosarcoma Grade II, Left Pelvis .g 837 to 1501 683 to 19   AAA   665/665
(100 %)
0 diff
(100 %id)
BU198967   .g 839 to 1323 1 to 485       485/485
(100 %)
4 diff
(99.2 %id)
BI117850 lung, small cell carcinoma .g 843 to 1494 1 to 654       654/801
(81 %)
4 diff
(99.6 %id)
CA424701 cell lines, Chondrosarcoma .g 857 to 1501 661 to 19   AAA   643/643
(100 %)
2 diff
(99.7 %id)
BQ575335 Chondrosarcoma Grade II, Left Pelvis .g 873 to 1501 647 to 19   AAA   629/629
(100 %)
0 diff
(100 %id)
BF220189 lung, small cell carcinoma .g 880 to 1433 565 to 1       565/782
(72 %)
19 diff
(97.6 %id)
BM826088 Ascites, stomach .g 880 to 1347 1 to 468       468/468
(100 %)
3 diff
(99.4 %id)
BM853212 Ascites, stomach .g 888 to 1477 1 to 590       590/590
(100 %)
0 diff
(100 %id)
BU596623 mixed (pool of 40 RNAs) .g 901 to 1502 1 to 601       601/604
(99 %)
4 diff
(99.4 %id)
AW021753 cochlea, ear .g 908 to 1232 1 to 325   fully sequenced,   325/325
(100 %)
4 diff
(98.8 %id)
BQ772629 Chondrosarcoma Cell line .g 913 to 1501 607 to 19   AAA   589/589
(100 %)
1 diff
(99.9 %id)
BQ009750 Chondrosarcoma, Left Pubic Bone .g 915 to 1501 604 to 19   AAA   586/586
(100 %)
4 diff
(99.4 %id)
BG998897 head_neck .g 926 to 1377 8 to 462       455/462
(98 %)
10 diff
(97.9 %id)
BU619827 Cell Line, Chondrosarcoma .g 926 to 1501 596 to 19   AAA   578/578
(100 %)
2 diff
(99.7 %id)
AW007782 colon .g 932 to 1471 540 to 1       540/541
(99 %)
0 diff
(100 %id)
BP242964 Liver .g 934 to 1355 1 to 422       422/580
(72 %)
11 diff
(98.2 %id)
W79102 heart .g 939 to 1150 1 to 221   fully sequenced,   221/221
(100 %)
1 diff
(99.6 %id)
BX408574 neuroblastoma .g 940 to 1502 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
BJ991123 hepatoblastoma .g 940 to 1419 480 to 1       480/480
(100 %)
0 diff
(100 %id)
AW055069 brain, glioblastoma (pooled) .g 964 to 1495 532 to 1       532/532
(100 %)
0 diff
(100 %id)
AW780230 colon, moderately-differentiated adenocarcinoma .g 969 to 1471 503 to 1       503/503
(100 %)
1 diff
(99.9 %id)
CA943749 Pancreas, Purified pancreatic islet .g 971 to 1502 535 to 4       532/535
(99 %)
0 diff
(100 %id)
BP393001 pancreatic islet .g 988 to 1501 1 to 514     Submitted on the opposite strand 514/514
(100 %)
1 diff
(99.9 %id)
N51714 multiple sclerosis lesions .g 989 to 1495 507 to 1       507/507
(100 %)
0 diff
(100 %id)
N51383 multiple sclerosis lesions .g 995 to 1495 500 to 1       500/500
(100 %)
3 diff
(99.4 %id)
BU532545 mixed (pool of 40 RNAs) .g 996 to 1399 1 to 404       404/953
(42 %)
11 diff
(98.9 %id)
AA171396   .g 999 to 1502 513 to 1       513/513
(100 %)
10 diff
(98.1 %id)
AW582384 stomach .g 1009 to 1146 1 to 143       143/143
(100 %)
10 diff
(93.1 %id)
AW390569 stomach .g 1015 to 1328 341 to 26       316/370
(85 %)
2 diff
(99.5 %id)
AW390641 stomach .g 1015 to 1325 313 to 6       308/338
(91 %)
0 diff
(100 %id)
AW609335 stomach .g 1015 to 1328 320 to 9       312/344
(90 %)
0 diff
(100 %id)
BE842735 stomach .g 1015 to 1321 324 to 18       307/350
(87 %)
4 diff
(98.9 %id)
BF375119 stomach .g 1015 to 1321 316 to 16       301/341
(88 %)
1 diff
(99.8 %id)
BF375124 stomach .g 1015 to 1322 318 to 14       305/343
(88 %)
0 diff
(100 %id)
AA004453 liver and spleen .g 1018 to 1470 456 to 1       456/456
(100 %)
3 diff
(99.4 %id)
AA004488 liver and spleen .g 1018 to 1470 464 to 1       462/465
(99 %)
9 diff
(98.1 %id)
BM853725 Ascites, stomach .g 1021 to 1315 1 to 295       295/295
(100 %)
1 diff
(99.7 %id)
AA873540 Kidney .g 1025 to 1501 477 to 1       477/477
(100 %)
0 diff
(100 %id)
DB380291 placenta .g 1026 to 1502 477 to 3       475/507
(93 %)
15 diff
(97.1 %id)
AI475743 B-cell, chronic lymphotic leukemia .g 1029 to 1502 474 to 1       474/474
(100 %)
0 diff
(100 %id)
AA884235 pooled .g 1030 to 1497 469 to 2       468/469
(99 %)
0 diff
(100 %id)
AI937113 anaplastic oligodendroglioma, brain .g 1030 to 1497 476 to 8       469/476
(98 %)
0 diff
(100 %id)
AA857925 adenocarcinoma, colon .g 1031 to 1502 479 to 8       472/479
(98 %)
0 diff
(100 %id)
AW071994 anaplastic oligodendroglioma, brain .g 1031 to 1502 472 to 1       472/472
(100 %)
1 diff
(99.8 %id)
T90646 liver and spleen .g 1032 to 1490 469 to 1       469/469
(100 %)
10 diff
(97.9 %id)
AA608743 lung, lung carcinoma .g 1033 to 1498 469 to 4       466/469
(99 %)
0 diff
(100 %id)
T90660 liver and spleen .g 1035 to 1490 464 to 1       464/465
(99 %)
8 diff
(98.3 %id)
C04048 heart .g 1036 to 1456 1 to 421       421/421
(100 %)
3 diff
(99.3 %id)
AI970713 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .g 1036 to 1502 468 to 2       467/468
(99 %)
0 diff
(100 %id)
BE709646 head_neck .g 1037 to 1368 334 to 2       333/349
(95 %)
1 diff
(99.8 %id)
C03792 heart .g 1037 to 1470 1 to 434       434/434
(100 %)
5 diff
(98.9 %id)
AA805444 germinal center B cell .g 1041 to 1495 459 to 11   AAA   449/451
(99 %)
8 diff
(98.3 %id)
BF108917 pooled .g 1041 to 1502 469 to 7       463/469
(98 %)
0 diff
(100 %id)
BF432367 brain, glioblastoma (pooled) .g 1042 to 1502 461 to 1       461/461
(100 %)
0 diff
(100 %id)
BX408571 neuroblastoma .g 1048 to 1502 1 to 453       453/453
(100 %)
4 diff
(99.2 %id)
AI074136 senescent fibroblast .g 1056 to 1501 456 to 11   AAA   446/446
(100 %)
0 diff
(100 %id)
AI301662 2 pooled tumors (clear cell type), Kidney .g 1059 to 1504 448 to 3       446/448
(99 %)
0 diff
(100 %id)
AA406358 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 1069 to 1502 434 to 1       434/434
(100 %)
0 diff
(100 %id)
AA223542 brain, neuroepithelial cells .g 1072 to 1502 432 to 1       432/433
(99 %)
1 diff
(99.8 %id)
AI084170 anaplastic oligodendroglioma, brain .g 1073 to 1497 426 to 2       425/426
(99 %)
0 diff
(100 %id)
AA609836 lung, lung carcinoma .g 1074 to 1497 424 to 1       424/424
(100 %)
9 diff
(97.9 %id)
AI469324 follicular lymphoma, lymph node .g 1079 to 1470 392 to 1       392/392
(100 %)
2 diff
(99.5 %id)
AI499324 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .g 1079 to 1497 438 to 20       419/438
(95 %)
0 diff
(100 %id)
W79816 heart .g 1089 to 1496 413 to 1   fully sequenced,   413/413
(100 %)
2 diff
(99.6 %id)
AA101731 lung, lung carcinoma .g 1089 to 1504 417 to 1   fully sequenced,   417/417
(100 %)
4 diff
(99.1 %id)
AI032812 liver and spleen .g 1093 to 1495 403 to 1       403/403
(100 %)
0 diff
(100 %id)
AI038966 liver and spleen .g 1093 to 1471 379 to 1       379/379
(100 %)
0 diff
(100 %id)
AI283513 pooled .g 1095 to 1469 375 to 1       375/375
(100 %)
2 diff
(99.5 %id)
BE045246 normal epithelium, thyroid .g 1104 to 1470 421 to 55   AAA   367/367
(100 %)
2 diff
(99.5 %id)
AA554492 lung, lung tumor .g 1108 to 1502 396 to 2       395/396
(99 %)
0 diff
(100 %id)
AA633717   .g 1108 to 1502 395 to 2       394/396
(99 %)
0 diff
(100 %id)
BQ680327 melanotic melanoma, cell line, skin .g 1108 to 1501 1 to 394   AAA   394/394
(100 %)
0 diff
(100 %id)
CF541065 lung .g 1113 to 1501 407 to 19   AAA   389/389
(100 %)
0 diff
(100 %id)
BM353441 Pancreas, Purified pancreatic islet .g 1117 to 1502 392 to 7       386/404
(95 %)
0 diff
(100 %id)
CD247379 embryonic stem cells, WA01, passage 38 .g 1117 to 1499 24 to 407   AAA   384/407
(94 %)
6 diff
(98.6 %id)
AI374713   .g 1126 to 1502 385 to 9       377/385
(97 %)
0 diff
(100 %id)
BG235933 blood, lymphocyte .g 1126 to 1501 377 to 2       376/377
(99 %)
0 diff
(100 %id)
AW377179 colon .g 1138 to 1298 165 to 5       161/165
(97 %)
0 diff
(100 %id)
AI261463 Kidney .g 1152 to 1501 364 to 15   AAA   350/350
(100 %)
1 diff
(99.8 %id)
AI952313 brain, three pooled meningiomas .g 1157 to 1502 348 to 3       346/348
(99 %)
0 diff
(100 %id)
AI252779 pooled .g 1170 to 1469 300 to 1       300/300
(100 %)
0 diff
(100 %id)
FN046038 breast carcinoma .g 1176 to 1247 75 to 6     Submitted on the opposite strand 70/76
(92 %)
0 diff
(100 %id)
AA347940 heart .g 1183 to 1501 318 to 1       318/318
(100 %)
3 diff
(99.1 %id)
F03919 brain, total brain .g 1195 to 1495 301 to 1       301/301
(100 %)
0 diff
(100 %id)
AA347678 heart .g 1197 to 1500 304 to 1       304/304
(100 %)
0 diff
(100 %id)
BI492692 cochlea, ear .g 1202 to 1506 305 to 1   fully sequenced,   305/305
(100 %)
2 diff
(99.4 %id)
BF055864 brain, oligodendroglioma .g 1207 to 1256 51 to 2     Submitted on the opposite strand 50/51
(98 %)
0 diff
(100 %id)
CD000089 Pooled-Skin .g 1216 to 1504 1 to 289   AAA   289/289
(100 %)
4 diff
(98.7 %id)
AW024810 Kidney .g 1230 to 1495 266 to 1       266/266
(100 %)
0 diff
(100 %id)
BX429640 neuroblastoma .g 1238 to 1502 1 to 265       265/270
(98 %)
3 diff
(98.9 %id)
AI698405 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .g 1244 to 1502 261 to 3       259/261
(99 %)
0 diff
(100 %id)
AA988713 Kidney, kidney tumor .g 1247 to 1501 255 to 1       255/255
(100 %)
1 diff
(99.7 %id)
AI367071   .g 1248 to 1501 268 to 15   AAA   254/254
(100 %)
0 diff
(100 %id)
BF798810 colon_ins .g 1250 to 1358 112 to 4     Submitted on the opposite strand 109/112
(97 %)
0 diff
(100 %id)
BX429705 neuroblastoma .g 1250 to 1502 1 to 254       254/261
(97 %)
6 diff
(97.8 %id)
AA358343 lung .g 1266 to 1501 236 to 1       236/236
(100 %)
2 diff
(99.2 %id)
BU732322 eye, RPE and Choroid .g 1276 to 1501 244 to 19   AAA   226/226
(100 %)
1 diff
(99.6 %id)
AA205107.
matches multiple genes
  .g 1364 to 1501 138 to 1     also hits gene CSTF3 138/138
(100 %)
0 diff
(100 %id)
CN308685 embryonic stem cells, DMSO-treated H9 cellline .h 1 to 392 1 to 392   tiling clone,   392/392
(100 %)
0 diff
(100 %id)
H09252 whole brain .h 335 to 679 1 to 354   tiling clone,   354/410
(86 %)
13 diff
(96.9 %id)
AA340189 brain .h 639 to 979 1 to 348       348/348
(100 %)
7 diff
(98.0 %id)
AA340346 brain .h 639 to 1015 1 to 380       380/380
(100 %)
4 diff
(99.0 %id)
AW952818   .h 640 to 1151 1 to 512   tiling clone,   512/514
(99 %)
2 diff
(99.7 %id)
H09253 whole brain .h 1106 to 1463 382 to 12   tiling clone, AAA   371/445
(83 %)
20 diff
(95.6 %id)
DA636808 Kidney .i 1 to 572 2 to 573   tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
CD579602 brain .i 496 to 1347 1 to 848 F101X tiling clone,   848/1093
(77 %)
30 diff
(97.3 %id)
BX404152 neuroblastoma .j 1 to 1080 1 to 1080 Y171F Q175X M199X I200N A201X ... tiling clone,   1080/1113
(97 %)
10 diff
(99.2 %id)
AK309183 thalamus .k 1 to 895 3 to 897 exact tiling clone,   897/897
(100 %)
2 diff
(99.8 %id)
TI_57179894   .k 20 to 823 29 to 830 I61M V62S R63A T64Q E65N ...     802/832
(96 %)
4 diff
(99.6 %id)
BI770394 pooled lung and spleen .k 21 to 823 1 to 801 I61M V62S R63A T64Q E65N ...     801/803
(99 %)
4 diff
(99.6 %id)
BF974404 B-cells, primary B-cells from tonsils (cell line) .k 27 to 811 1 to 789 E71D Y72I K73* tiling clone,   789/1085
(72 %)
13 diff
(98.9 %id)
CN308710 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .m 1 to 645 4 to 648 R47P C64W tiling clone,   648/651
(99 %)
3 diff
(99.6 %id)
DA055730 cerebellum .n 1 to 504 2 to 507 L30X D31G L32F D33G I34Y ... tiling clone, capped   506/506
(100 %)
4 diff
(99.3 %id)
AL713581 human skeletal muscle .o-u 213 to 462 1 to 250 exact tiling clone,   250/250
(100 %)
0 diff
(100 %id)
AI985696 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .p-u 1 to 448 448 to 1 exact tiling clone,   448/448
(100 %)
0 diff
(100 %id)
AV703081 adrenal gland Gene CCNB1IP1, variant not shown         Suspected internal deletion, this clone was ignored    
AV697282 hepatocellular carcinoma Gene CCNB1IP1, variant not shown         Suspected internal deletion, this clone was ignored    
AV687003 hepatocellular carcinoma Gene CCNB1IP1, variant not shown         Suspected internal deletion, this clone was ignored    
AV687041 hepatocellular carcinoma Gene CCNB1IP1, variant not shown         This clone was ignored    
AV744618 cord Blood Gene CCNB1IP1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
GD151169   Gene CCNB1IP1, variant not shown              
CN308705 embryonic stem cells, DMSO-treated H9 cellline Gene CCNB1IP1, variant not shown         This clone was ignored    
CN308716 embryonic stem cells, DMSO-treated H9 cellline Gene CCNB1IP1, variant not shown         This clone was ignored    
BX334446 Placenta Cot 25-normalized Gene CCNB1IP1, variant not shown       fully sequenced, This clone was ignored    
BX334445 Placenta Cot 25-normalized Gene CCNB1IP1, variant not shown       fully sequenced, This clone was ignored    
BX161424 placenta Gene CCNB1IP1, variant not shown         Suspected internal deletion, this clone was ignored    
AW301202 Kidney Gene CCNB1IP1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BF791873 adrenal cortex carcinoma, cell line, adrenal gland Gene CCNB1IP1, variant not shown         This clone was ignored    
BG284298 adenocarcinoma, cell line, Prostate Gene CCNB1IP1, variant not shown              
BI763317 pooled colon, kidney, stomach Gene CCNB1IP1, variant not shown         This clone was ignored    
TI_57150150   Gene CCNB1IP1, variant not shown       AAA This clone was ignored    
NM_182852.2   Gene CCNB1IP1, variant not shown       RefSeq, AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n, .o-u, .p-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI